Hiddo J. Heerspink
Groningen, GR, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
SGLT2 inhibition in Patients with Type 2 Diabetes and CKD Experiencing a Deterioration in Estimated Glomerular Filtration Rate to <20ml/min/1.73m2.
Journal: Journal of cardiac failure
Published: December 01, 2025
Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: July 07, 2025
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria.
Journal: American heart journal
Published: January 12, 2024
People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action.
Journal: The lancet. Diabetes & endocrinology
Published: May 26, 2023
UHPLC-MS/MS method for iohexol determination in human EDTA and lithium-heparin plasma, human urine and in goat- and pig EDTA plasma.
Journal: Bioanalysis
Published: July 23, 2020
Report from the 5th cardiovascular outcome trial (CVOT) summit.
Journal: Cardiovascular diabetology
Published: March 17, 2020
Evaluation of renal and cardiovascular protection mechanisms of SGLT2 inhibitors: model-based analysis of clinical data.
Journal: American journal of physiology. Renal physiology
Published: July 19, 2018
Predictive Properties of Biomarkers GDF-15, NTproBNP, and hs-TnT for Morbidity and Mortality in Patients With Type 2 Diabetes With Nephropathy.
Journal: Diabetes care
Published: October 10, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026